Addiction Toxicology Case Conference - April 2026

Addiction Toxicology Case Conference - April 2026

  • Register
    • Non-member - Tier I - Free!
    • Non-member - Tier II - Free!
    • Non-member - Tier III - Free!
    • Non-member - Tier IV - Free!
    • Member - Tier I - Free!
    • Member - Tier II - Free!
    • Member - Tier III - Free!
    • Member - Tier IV - Free!

Gastric Bypass and the Effect on Addiction and SUD

Friday, April 3, 2026
1:00-2:00pm ET

Case 1: A 38 year-old female with borderline PD and history of gastric bypass about 9 months prior denies any history of SUD has had escalating problems with alcohol use. Her mother (whom she lives with) is about to kick her out, she drank during an attempt at ambulatory w/d 3 months prior and missed follow up apts reaching out now "pleading' for another chance.

Case 2: Involves a female who had gastric bypass no prior SUD within months of bypass drinking rapidly escalating to 10-12 White Claws a day. Reached out to the IOP I was at because I offered ambulatory w/d treatment. She took 800 mg PO TID gabapentin.


Learning Objectives

1.) Describe how gastric bypass effects risk of development of AUD after bariatric surgery

2.) Describe one method of performing ambulatory w/d including medications used, screening process (risk/benefit) and other preparation.


About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.

This webinar is free and open to the public.

Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)

Director and CEO, Toxicology Consulting

Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)

Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.

Gloria Baciewicz, MD (Moderator)

Addiction Psychiatrist

Strong Recovery

Since 1986, Dr. Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.

Maria Owen

LCSW-R Supervisor of Clinic Services

Leslie R. Dye, MD, FACMT, FASAM

Medical Director, Next Life Recovery

Clinical Professor, Department of Emergency Medicine, Boonshoft School of Medicine, Wright State University

Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

Key:

Complete
Failed
Available
Locked
Attendance: Who's Watching?
8 Questions
8 Questions Help us track metrics for our webinar series by answering these quick questions.
ATCC - April 2026
04/03/2026 at 1:00 PM (EDT)  |  60 minutes
04/03/2026 at 1:00 PM (EDT)  |  60 minutes
Feedback Survey
5 Questions
Attendance Certificate
Live and Archive Viewing: No credits available and certificate available
Live and Archive Viewing: No credits available and certificate available This is an optional certificate verifying that you attended this webinar. Please note that this is NOT a certificate for continuing education credits.